Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination

References

• Conticello SG. The AID/APOBEC family of nucleic acid mutators. Genome Biol 2008; 9:229; http://dx.doi.org/10.1186/gb-2008-9-6-229; PMID: 18598372
   PubMed Web of Science ®Google Scholar
• Albin JS, Harris RS. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med 2010; 12:e4; http://dx.doi.org/10.1017/S1462399409001343; PMID: 20096141
   PubMed Web of Science ®Google Scholar
• Larue RS, Lengyel J, Jónsson SR, Andrésdóttir V, Harris RS. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity. J Virol 2010; 84:8193 - 201; http://dx.doi.org/10.1128/JVI.00685-10; PMID: 20519393
   PubMed Web of Science ®Google Scholar
• Malim MH, Emerman M. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe 2008; 3:388 - 98; http://dx.doi.org/10.1016/j.chom.2008.04.008; PMID: 18541215
   PubMed Web of Science ®Google Scholar
• Aguiar RS, Peterlin BM. APOBEC3 proteins and reverse transcription. Virus Res 2008; 134:74 - 85; http://dx.doi.org/10.1016/j.virusres.2007.12.022; PMID: 18262674
   PubMed Web of Science ®Google Scholar
• Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, et al. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J Virol 2011; 85:11220 - 34; http://dx.doi.org/10.1128/JVI.05238-11; PMID: 21835787
   PubMed Web of Science ®Google Scholar
• Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197:1173 - 81; http://dx.doi.org/10.1084/jem.20030275; PMID: 12732658
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Bhagat G, Jankovic M, Compagno M, Smith P, Muramatsu M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 2008; 40:108 - 12; http://dx.doi.org/10.1038/ng.2007.35; PMID: 18066064
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S, et al. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008; 135:1028 - 38; http://dx.doi.org/10.1016/j.cell.2008.09.062; PMID: 19070574
   PubMed Web of Science ®Google Scholar
• Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, et al. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem 1996; 271:25981 - 8; http://dx.doi.org/10.1074/jbc.271.42.25981; PMID: 8824235
   PubMed Web of Science ®Google Scholar
• Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A 1995; 92:8483 - 7; http://dx.doi.org/10.1073/pnas.92.18.8483; PMID: 7667315
   PubMed Web of Science ®Google Scholar
• Suspène R, Aynaud MM, Guétard D, Henry M, Eckhoff G, Marchio A, et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A 2011; 108:4858 - 63; http://dx.doi.org/10.1073/pnas.1009687108; PMID: 21368204
   PubMed Web of Science ®Google Scholar
• Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep 2011; 12:444 - 50; http://dx.doi.org/10.1038/embor.2011.46; PMID: 21460793
   PubMed Web of Science ®Google Scholar
• Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 2013; http://dx.doi.org/10.1038/nature11881; PMID: 23389445
   PubMed Web of Science ®Google Scholar
• Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391:43 - 50; http://dx.doi.org/10.1038/34112; PMID: 9422506
   PubMed Web of Science ®Google Scholar
• Reich NC, Liu L. Tracking STAT nuclear traffic. Nat Rev Immunol 2006; 6:602 - 12; http://dx.doi.org/10.1038/nri1885; PMID: 16868551
   PubMed Web of Science ®Google Scholar
• Pelzer C, Thome M. IKKα takes control of canonical NF-κB activation. Nat Immunol 2011; 12:815 - 6; http://dx.doi.org/10.1038/ni.2082; PMID: 21852778
   PubMed Web of Science ®Google Scholar
• Yoneda Y. Nucleocytoplasmic protein traffic and its significance to cell function. Genes Cells 2000; 5:777 - 87; http://dx.doi.org/10.1046/j.1365-2443.2000.00366.x; PMID: 11029654
   PubMed Web of Science ®Google Scholar
• Güttinger S, Laurell E, Kutay U. Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol 2009; 10:178 - 91; http://dx.doi.org/10.1038/nrm2641; PMID: 19234477
   PubMed Web of Science ®Google Scholar
• Estrada-Gelonch A, Aramburu J, López-Rodríguez C. Exclusion of NFAT5 from mitotic chromatin resets its nucleo-cytoplasmic distribution in interphase. PLoS One 2009; 4:e7036; http://dx.doi.org/10.1371/journal.pone.0007036; PMID: 19750013
   PubMedGoogle Scholar
• Zaidi SK, Young DW, Pockwinse SM, Javed A, Lian JB, Stein JL, et al. Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells. Proc Natl Acad Sci U S A 2003; 100:14852 - 7; http://dx.doi.org/10.1073/pnas.2533076100; PMID: 14657346
   PubMed Web of Science ®Google Scholar
• Niewiadomska AM, Tian C, Tan L, Wang T, Sarkis PT, Yu XF. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J Virol 2007; 81:9577 - 83; http://dx.doi.org/10.1128/JVI.02800-06; PMID: 17582006
   PubMed Web of Science ®Google Scholar
• Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A, Kurata T, et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 2007; 35:2955 - 64; http://dx.doi.org/10.1093/nar/gkm181; PMID: 17439959
   PubMed Web of Science ®Google Scholar
• Marin M, Golem S, Rose KM, Kozak SL, Kabat D. Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism. J Virol 2008; 82:987 - 98; http://dx.doi.org/10.1128/JVI.01078-07; PMID: 17977970
   PubMed Web of Science ®Google Scholar
• Muckenfuss H, Hamdorf M, Held U, Perkovic M, Löwer J, Cichutek K, et al. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 2006; 281:22161 - 72; http://dx.doi.org/10.1074/jbc.M601716200; PMID: 16735504
   PubMed Web of Science ®Google Scholar
• Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 2006; 16:480 - 5; http://dx.doi.org/10.1016/j.cub.2006.01.031; PMID: 16527742
   PubMed Web of Science ®Google Scholar
• Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity. Retrovirology 2007; 4:61; http://dx.doi.org/10.1186/1742-4690-4-61; PMID: 17727729
   PubMed Web of Science ®Google Scholar
• Bogerd HP, Wiegand HL, Doehle BP, Lueders KK, Cullen BR. APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res 2006; 34:89 - 95; http://dx.doi.org/10.1093/nar/gkj416; PMID: 16407327
   PubMed Web of Science ®Google Scholar
• OhAinle M, Kerns JA, Li MM, Malik HS, Emerman M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 2008; 4:249 - 59; http://dx.doi.org/10.1016/j.chom.2008.07.005; PMID: 18779051
   PubMed Web of Science ®Google Scholar
• Lackey L, Demorest ZL, Land AM, Hultquist JF, Brown WL, Harris RS. APOBEC3B and AID have similar nuclear import mechanisms. J Mol Biol 2012; 419:301 - 14; http://dx.doi.org/10.1016/j.jmb.2012.03.011; PMID: 22446380
   PubMed Web of Science ®Google Scholar
• Patenaude AM, Orthwein A, Hu Y, Campo VA, Kavli B, Buschiazzo A, et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 2009; 16:517 - 27; http://dx.doi.org/10.1038/nsmb.1598; PMID: 19412186
   PubMed Web of Science ®Google Scholar
• McBride KM, Barreto V, Ramiro AR, Stavropoulos P, Nussenzweig MC. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J Exp Med 2004; 199:1235 - 44; http://dx.doi.org/10.1084/jem.20040373; PMID: 15117971
   PubMed Web of Science ®Google Scholar
• Ito S, Nagaoka H, Shinkura R, Begum N, Muramatsu M, Nakata M, et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci U S A 2004; 101:1975 - 80; http://dx.doi.org/10.1073/pnas.0307335101; PMID: 14769937
   PubMed Web of Science ®Google Scholar
• Yang Y, Sowden MP, Yang Y, Smith HC. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA. Exp Cell Res 2001; 267:153 - 64; http://dx.doi.org/10.1006/excr.2001.5255; PMID: 11426934
   PubMed Web of Science ®Google Scholar
• Blanc V, Kennedy S, Davidson NO. A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling. J Biol Chem 2003; 278:41198 - 204; http://dx.doi.org/10.1074/jbc.M302951200; PMID: 12896982
   PubMed Web of Science ®Google Scholar
• Blanc V, Henderson JO, Kennedy S, Davidson NO. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity. J Biol Chem 2001; 276:46386 - 93; http://dx.doi.org/10.1074/jbc.M107654200; PMID: 11571303
   PubMed Web of Science ®Google Scholar
• Bennett RP, Presnyak V, Wedekind JE, Smith HC. Nuclear Exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding. J Biol Chem 2008; 283:7320 - 7; http://dx.doi.org/10.1074/jbc.M708567200; PMID: 18165230
   PubMed Web of Science ®Google Scholar
• Stenglein MD, Harris RS. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem 2006; 281:16837 - 41; http://dx.doi.org/10.1074/jbc.M602367200; PMID: 16648136
   PubMed Web of Science ®Google Scholar
• Stenglein MD, Matsuo H, Harris RS. Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization. J Virol 2008; 82:9591 - 9; http://dx.doi.org/10.1128/JVI.02471-07; PMID: 18667511
   PubMed Web of Science ®Google Scholar
• Wichroski MJ, Robb GB, Rana TM. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog 2006; 2:e41; http://dx.doi.org/10.1371/journal.ppat.0020041; PMID: 16699599
   PubMedGoogle Scholar
• Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003; 424:99 - 103; http://dx.doi.org/10.1038/nature01709; PMID: 12808466
   PubMed Web of Science ®Google Scholar
• Gallois-Montbrun S, Holmes RK, Swanson CM, Fernández-Ocaña M, Byers HL, Ward MA, et al. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J Virol 2008; 82:5636 - 42; http://dx.doi.org/10.1128/JVI.00287-08; PMID: 18367521
   PubMed Web of Science ®Google Scholar
• Gallois-Montbrun S, Kramer B, Swanson CM, Byers H, Lynham S, Ward M, et al. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 2007; 81:2165 - 78; http://dx.doi.org/10.1128/JVI.02287-06; PMID: 17166910
   PubMed Web of Science ®Google Scholar
• Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006; 43:1364 - 74; http://dx.doi.org/10.1002/hep.21187; PMID: 16729314
   PubMed Web of Science ®Google Scholar
• Nowarski R, Wilner OI, Cheshin O, Shahar OD, Kenig E, Baraz L, et al. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood 2012; 120:366 - 75; http://dx.doi.org/10.1182/blood-2012-01-402123; PMID: 22645179
   PubMed Web of Science ®Google Scholar
• Brar SS, Watson M, Diaz M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J Biol Chem 2004; 279:26395 - 401; http://dx.doi.org/10.1074/jbc.M403503200; PMID: 15087440
   PubMed Web of Science ®Google Scholar
• Pak V, Heidecker G, Pathak VK, Derse D. The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B. J Virol 2011; 85:8538 - 47; http://dx.doi.org/10.1128/JVI.02645-10; PMID: 21715505
   PubMed Web of Science ®Google Scholar
• OhAinle M, Kerns JA, Malik HS, Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol 2006; 80:3853 - 62; http://dx.doi.org/10.1128/JVI.80.8.3853-3862.2006; PMID: 16571802
   PubMed Web of Science ®Google Scholar
• Wang X, Abudu A, Son S, Dang Y, Venta PJ, Zheng YH. Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. J Virol 2011; 85:3142 - 52; http://dx.doi.org/10.1128/JVI.02049-10; PMID: 21270145
   PubMed Web of Science ®Google Scholar
• Martin RM, Cardoso MC. Chromatin condensation modulates access and binding of nuclear proteins. FASEB J 2010; 24:1066 - 72; http://dx.doi.org/10.1096/fj.08-128959; PMID: 19897663
   PubMed Web of Science ®Google Scholar
• Wolff B, Sanglier JJ, Wang Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol 1997; 4:139 - 47; http://dx.doi.org/10.1016/S1074-5521(97)90257-X; PMID: 9190288
   PubMed Web of Science ®Google Scholar
• Harper JV. Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol 2005; 296:157 - 66; PMID: 15576930
   PubMedGoogle Scholar
• Hasham MG, Donghia NM, Coffey E, Maynard J, Snow KJ, Ames J, et al. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol 2010; 11:820 - 6; http://dx.doi.org/10.1038/ni.1909; PMID: 20657597
   PubMed Web of Science ®Google Scholar
• Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y, Shindo K, et al. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 2008; 452:116 - 9; http://dx.doi.org/10.1038/nature06638; PMID: 18288108
   PubMed Web of Science ®Google Scholar
• Chelico L, Pham P, Calabrese P, Goodman MF. APOBEC3G DNA deaminase acts processively 3′ --> 5′ on single-stranded DNA. Nat Struct Mol Biol 2006; 13:392 - 9; http://dx.doi.org/10.1038/nsmb1086; PMID: 16622407
   PubMed Web of Science ®Google Scholar
• LaRue RS, Jónsson SR, Silverstein KA, Lajoie M, Bertrand D, El-Mabrouk N, et al. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol Biol 2008; 9:104; http://dx.doi.org/10.1186/1471-2199-9-104; PMID: 19017397
   PubMed Web of Science ®Google Scholar
• Jónsson SR, Haché G, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS. Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins. Nucleic Acids Res 2006; 34:5683 - 94; http://dx.doi.org/10.1093/nar/gkl721; PMID: 17038330
   PubMed Web of Science ®Google Scholar
• Lassen KG, Wissing S, Lobritz MA, Santiago M, Greene WC. Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif. J Biol Chem 2010; 285:29326 - 35; http://dx.doi.org/10.1074/jbc.M110.154054; PMID: 20624919
   PubMed Web of Science ®Google Scholar
• Schrader CE, Guikema JE, Linehan EK, Selsing E, Stavnezer J. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J Immunol 2007; 179:6064 - 71; PMID: 17947680
   PubMed Web of Science ®Google Scholar
• Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 2010; 17:222 - 9; http://dx.doi.org/10.1038/nsmb.1744; PMID: 20062055
   PubMed Web of Science ®Google Scholar
• Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res 2010; 38:4274 - 84; http://dx.doi.org/10.1093/nar/gkq174; PMID: 20308164
   PubMed Web of Science ®Google Scholar
• Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM, Malim MH. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 2009; 83:9474 - 85; http://dx.doi.org/10.1128/JVI.01089-09; PMID: 19587057
   PubMed Web of Science ®Google Scholar
• Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3:e63; http://dx.doi.org/10.1371/journal.pgen.0030063; PMID: 17447845
   PubMedGoogle Scholar
• Duggal NK, Malik HS, Emerman M. The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection. J Virol 2011; 85:11361 - 71; http://dx.doi.org/10.1128/JVI.05046-11; PMID: 21835794
   PubMed Web of Science ®Google Scholar
• Dang Y, Abudu A, Son S, Harjes E, Spearman P, Matsuo H, et al. Identification of a single amino acid required for APOBEC3 antiretroviral cytidine deaminase activity. J Virol 2011; 85:5691 - 5; http://dx.doi.org/10.1128/JVI.00243-11; PMID: 21430060
   PubMed Web of Science ®Google Scholar
• Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004; 118:431 - 8; http://dx.doi.org/10.1016/j.cell.2004.08.006; PMID: 15315756
   PubMed Web of Science ®Google Scholar
• Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al, Breast Cancer Working Group of the International Cancer Genome Consortium. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149:979 - 93; http://dx.doi.org/10.1016/j.cell.2012.04.024; PMID: 22608084
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, et al, Oslo Breast Cancer Consortium (OSBREAC). The landscape of cancer genes and mutational processes in breast cancer. Nature 2012; 486:400 - 4; PMID: 22722201
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153 - 8; http://dx.doi.org/10.1038/nature05610; PMID: 17344846
   PubMed Web of Science ®Google Scholar
• Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333:1154 - 7; http://dx.doi.org/10.1126/science.1206923; PMID: 21798897
   PubMed Web of Science ®Google Scholar
• Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330:228 - 31; http://dx.doi.org/10.1126/science.1196333; PMID: 20826764
   PubMed Web of Science ®Google Scholar
• Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467:1114 - 7; http://dx.doi.org/10.1038/nature09515; PMID: 20981102
   PubMed Web of Science ®Google Scholar
• Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470:214 - 20; http://dx.doi.org/10.1038/nature09744; PMID: 21307934
   PubMed Web of Science ®Google Scholar
• Carpenter MA, Li M, Rathore A, Lackey L, Law EK, Land AM, et al. Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A. J Biol Chem 2012; 287:34801 - 8; http://dx.doi.org/10.1074/jbc.M112.385161; PMID: 22896697
   PubMed Web of Science ®Google Scholar
• Demorest ZL, Li M, Harris RS. Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein. J Biol Chem 2011; 286:26568 - 75; http://dx.doi.org/10.1074/jbc.M111.235721; PMID: 21659520
   PubMed Web of Science ®Google Scholar